title: Risk factors of thyroid cancer in Babol, Northern Iran.
abstract: Background : Thyroid cancer is the most common endocrine malignancy. Several risk factors were found to play a role in thyroid cancer. The purpose of the study was to determine the risk factors for thyroid cancer, in Babol, north of Iran.
  
  
  METHODS
  Eighty patients with thyroid cancer were selected as case group and 160 people living in the neighborhood of the patients as control group. Risk factors in both groups were collected and compared. The odds ratio (OR) as well as the marginal logistic regression model were used to estimate the possible risk factors. Result : X-ray exposure, radioactive exposure, family history of thyroid cancer, history of hyperthyroidism, hypothyroidism and thyroid resection were found to be the risk factors of thyroid cancer (p<0.05). Passion exposure, OCP user, history of hysterectomy, history of thyroid nodule were not correlated to thyroid cancer (p>0.05).
  
  
  CONCLUSIONS
  History of goiter or other benign thyroid diseases are among the thyroid cancer risk factors in some community-based interventions to prevent or treat the disease in early stages are recommended in our region.
authors.affiliation: Department of Internal Medicine, Babol University of Medical Sciences, Babol, Iran.
authors.forename: Zoleika
authors.initials: Z
authors.lastname: Moazezi
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Mahmoudi
authors.forename: Yousef
authors.initials: Y
authors.lastname: Yahyahpour
authors.forename: Alireza
authors.initials: A
authors.lastname: Alaleh
keywords: Thyroid cancer; case - control study; odds ratio; risk factors
references.citation: Ann Chir. 1998;52(5):444-8
references.pmid: 9752484
references.citation: Cancer. 1973 Mar;31(3):600-5
references.pmid: 4693587
references.citation: Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):991-7
references.pmid: 10566554
references.citation: J Endocrinol Invest. 2003;26(2 Suppl):71-6
references.pmid: 12762644
references.citation: Clin Endocrinol (Oxf). 2003 Jan;58(1):43-8
references.pmid: 12519411
references.citation: Cancer Epidemiol Biomarkers Prev. 1996 Jun;5(6):425-31
references.pmid: 8781737
references.citation: Clin Endocrinol (Oxf). 1999 Feb;50(2):191-6
references.pmid: 10396361
references.citation: J Natl Cancer Inst. 1987 Jul;79(1):1-12
references.pmid: 3474436
references.citation: J Natl Cancer Inst. 2005 May 18;97(10):703-5
references.pmid: 15900034
references.citation: CA Cancer J Clin. 2005 Jan-Feb;55(1):7-9
references.pmid: 15661683
references.citation: Surgery. 1999 Dec;126(6):1183-7
references.pmid: 10598205
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):979-85
references.pmid: 11535551
references.citation: J Nucl Med. 2000 Jun;41(6):1006-9
references.pmid: 10855625
references.citation: J Clin Endocrinol Metab. 2004 May;89(5):2281-9
references.pmid: 15126554
references.citation: Surg Clin North Am. 1987 Apr;67(2):343-57
references.pmid: 3551149
references.citation: Thyroid. 2006 Feb;16(2):109-42
references.pmid: 16420177
references.citation: Eur J Intern Med. 2003 Aug;14(5):321-325
references.pmid: 13678758
references.citation: Oncol Rep. 2003 Jan-Feb;10(1):133-6
references.pmid: 12469158
references.citation: Surgery. 1987 Jun;101(6):649-60
references.pmid: 3589961
references.citation: Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):193-9
references.pmid: 7606193
references.citation: J Clin Pathol. 1984 Dec;37(12):1370-8
references.pmid: 6511982